Finasteride Tablet, Film Coated
Product Images NDC 67877-288

8 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 67877-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structutre (Finasteride Structure)

Structutre (Finasteride Structure)
Chemical structure diagram of Finasteride, the active ingredient in the product labeled as Finasteride 5 mg film-coated tablets by Ascend Laboratories, LLC.*
FDA Label Image

Finasteride-fig.1 (Finasteride Fig.1)

Finasteride-fig.1 (Finasteride Fig.1)
A line graph showing the mean change from baseline with standard error over four years for Finasteride 5 mg oral tablets versus placebo. The y-axis represents mean change from baseline, and the x-axis represents time points at baseline and each year up to year 4. The graph shows greater improvement over time with Finasteride compared to placebo, with sample sizes labeled for each time point.*
FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

Finasteride-fig.2 (Finasteride Fig.2)
A line chart comparing the percentage of patients over a 48-month observation period between Finasteride and Placebo groups. The graph shows cumulative patient percentages on the y-axis and observation time in months on the x-axis. Data tables below the graph provide cumulative event counts and number of patients at risk per year for both Placebo and Finasteride groups.*
FDA Label Image

Finasteride-fig.3 (Finasteride Fig.3)

Finasteride-fig.3 (Finasteride Fig.3)
A line graph comparing the mean percent change from baseline plus one standard error over four years between two groups: Placebo and Finasteride. The x-axis shows time points from baseline to year 4, with sample sizes for each group displayed below. The y-axis indicates percent change, ranging from -20 to 20. Placebo group data points increase positively over time, while Finasteride group data points decline negatively and stabilize after year 1.*
FDA Label Image

Finasteride-fig4a (Finasteride Fig4a)

Finasteride-fig4a (Finasteride Fig4a)
A line graph showing mean percent change from baseline ± 1 SE over four years for two groups: placebo and finasteride, with sample sizes noted at each time point from baseline to year 4. The placebo group shows increasing positive percent change, while the finasteride group shows a decrease stabilizing below baseline after year 1.*
FDA Label Image

Finasteride-fig.5 (Finasteride Fig.5)

Finasteride-fig.5 (Finasteride Fig.5)
A line graph depicting the percent of subjects experiencing an event over years from randomization (0 to 5.5 years). It compares four groups: Placebo, Finasteride, Doxazosin, and Combination, showing the highest event percentage with Placebo and the lowest with Combination over time.*
FDA Label Image

Finasteride-5mg-30tabs (Finasteride 5mg 30tabs)

Finasteride-5mg-30tabs (Finasteride 5mg 30tabs)
Finasteride tablets, USP 5 mg film-coated oral tablets in a 30-tablet package by Ascend Laboratories, LLC. The label includes dosage instructions, storage conditions, manufacturer details (Alkem Laboratories Ltd., Mumbai, India), and warnings that the product is not for women or children. It features the product name, strength, NDC 67877-288-30, barcodes, and placeholder for batch details with a QR code area.*
FDA Label Image

Finasteride-5mg-500tab (Finasteride 5mg 500tabs)

Finasteride-5mg-500tab (Finasteride 5mg 500tabs)
Label for Finasteride Tablets, USP 5 mg, film-coated oral tablets, supplied in a bottle of 500 tablets. Label includes usage warnings, storage instructions, and specifies Rx only. Manufactured by Alkem Laboratories Ltd., India and distributed by Ascend Laboratories, LLC. Shows the NDC 67877-288-05 barcode and a designated varnish area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.